Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

[Affective and psychotic disorders in multiple sclerosis].
Temporal reorganization to overcome monocular demyelination.
Relevance of brain lesion location to cognition in relapsing multiple sclerosis.
Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.
Anesthetic management of a patient with multiple sclerosis undergoing cesarean section with low dose epidural bupivacaine.
Future treatment approaches to multiple sclerosis.
Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis.
Multiple sclerosis presenting as a relapsing amnestic syndrome.
Meta-analysis of prevalence.
Relapsing and progressive forms of multiple sclerosis: insights from pathology.
Prevalence of temporomandibular disorders symptoms in patients with multiple sclerosis.
[Expression of human B-cell specific receptor FCRL1 in normal individuals and in patients with autoimmune diseases].
Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
Sexual dysfunction in multiple sclerosis: A 6-year follow-up study.
Deep brain stimulation of the ventral intermediate nucleus of the thalamus for tremor in patients with multiple sclerosis.
Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D.
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Treatment patterns in multiple sclerosis: administrative claims analysis over 10 years.
Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.
Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.
Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease.
Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature.
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo (irmsrct)
Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis.
Information provision for people with multiple sclerosis.

Pages